The company said net sales for Q3 2024 rose to $5,033 million from $4,915 million a year earlier, up 2.4%, and that organic sales, a non-GAAP measure, rose 6.8%.

1. 01

   The company said net sales for Q3 2024 rose to $5,033 million from $4,915 million a year earlier, up 2.4%, and that organic sales, a non-GAAP measure, rose 6.8%.

2. 02

   Colgate-Palmolive said its GAAP gross profit margin for Q3 2024 was 61.1%, up 260 basis points. It said GAAP diluted EPS was $0.90 and Base Business EPS was $0.91.

3. 03

   The company reported net cash provided by operations of $2,838 million for the first 9 months of 2024. It said free cash flow before dividends, after deducting capital expenditures of $377 million, was $2,461 million.

4. 04

   Colgate-Palmolive set its 2024 full-year net sales growth outlook at 3% to 5%, versus 2% to 5% previously, and its organic sales growth outlook at 7% to 8%, versus 6% to 8% previously. It said its Base Business EPS growth outlook is 10% to 11%, versus 8% to 11% previously.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.